Blue 生物技術市場報告：2030 年趨勢、預測與競爭分析

藍色生物技術趨勢與預測

預計2024年至2030年全球藍色生物技術市場將以13.9%的複合年成長率成長。該市場的主要促進因素是需求的增加、舉措。全球藍色生物技術市場的未來前景廣闊，醫院、製藥公司、生技公司、研究機構和實驗室市場都有機會。

Lucintel 預測酵素將在預測期內達到最高成長。

在這個市場中，藥品將繼續成為最大的細分市場。

由於其廣泛的醫療和研究設施，北美在預測期內仍然是最大的地區。

常問問題

Q1.市場成長預測是多少：

A1. 2024年至2030年，全球藍色生物技術市場預計將以13.9%的複合年成長率成長。

Q2. 影響市場成長的關鍵促進因素是：

A2. 該市場的主要促進因素是需求的增加、研發舉措。

Q3.市場的主要細分市場是：

A3.藍色生技市場未來性廣闊，醫院、製藥公司、生技公司、研究機構、實驗室市場都有機會。

Q4.市場的主要企業是：

A4. 主要的藍色生技公司如下：

• Aker BioMarine
• Marinova
• New England BioLabs
• PML Applications
• Sea Run Holdings
• PICES
• Donald Danforth Plant Science Center
• Shell Marine Products
• Geomarine Biotechnologies
• GlycoMar

Q5.未來最大的細分市場是什麼？

A5.Lucintel 預測酵素在預測期內將出現最高成長。

Q6.未來五年預計哪些地區的市場成長最大？

A6. 由於其廣泛的醫療和研究設施，北美在預測期內仍將是最大的地區。

Q7. 可以客製化報告嗎？

A7。

目錄

第1章執行摘要

第2章全球藍色生物技術市場：市場動態

• 簡介、背景、分類
• 供應鏈
• 產業促進因素與挑戰

第3章 2018-2030年市場趨勢及預測分析

• 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
• 全球藍色生物技術市場趨勢（2018-2023）與預測（2024-2030）
• 按產品分類的環球藍聯生物技術市場
  • 酵素
  • 藥品
  • 大宗化學品
  • 生物聚合物
  • 其他
• 按應用分類的環球藍聯生物技術市場
  • 生物工程
  • 基因組學
  • 疫苗開發
  • 藥物發現
  • 其他
• 以最終用途分類的環球藍聯生物技術市場
  • 醫院
  • 製藥公司
  • 生技公司
  • 研究所
  • 研究所
  • 其他

第4章 2018-2030年區域市場趨勢及預測分析

• 全球藍色生物技術市場區域分佈
• 北美藍色生物技術市場
• 歐洲藍色生物技術市場
• 亞太藍色生物科技市場
• 其他地區藍色生物科技市場

第5章 競爭分析

• 產品系列分析
• 營運整合
• 波特五力分析

第6章 成長機會與策略分析

• 成長機會分析
  • 環球藍聯生物技術市場成長機會（按產品）
  • 全球藍色生物技術市場應用的成長機會
  • 環球藍聯生物技術市場成長機會（依最終用途）
  • 按地區分類的環球藍聯生物技術市場成長機會
• 全球藍色生物技術市場的新興趨勢
• 戰略分析
  • 新產品開發
  • 擴大全球藍色生物技術市場的產能
  • 全球藍色生物技術市場的併購和合資企業
  • 認證和許可

第7章主要企業概況

• Aker BioMarine
• Marinova
• New England BioLabs
• PML Applications
• Sea Run Holdings
• PICES
• Donald Danforth Plant Science Center
• Shell Marine Products
• Geomarine Biotechnologies
• GlycoMar

Blue Biotechnology Trends and Forecast

The future of the global blue biotechnology market looks promising with opportunities in the hospitals, pharmaceutical companies, biotechnology companies, research institutes, and laboratories markets. The global blue biotechnology market is expected to grow with a CAGR of 13.9% from 2024 to 2030. The major drivers for this market are increasing demand in the pharmaceutical and cosmetics sectors and growing R&D expenditures and initiatives.

Lucintel forecasts that enzymes is expected to witness the highest growth over the forecast period.

Within this market, pharmaceutical will remain the largest segment.

North America will remain the largest region over the forecast period due to the presence of improved and advanced healthcare and research facilities in the region.

Emerging Trends in the Blue Biotechnology Market

There are several major trends emerging regarding the future outlook of the blue biotechnology market. Developments in marine genomics, environmental protection measures, and novel applications have played a key role in these growth strategies while creating new business opportunities as well. These trends reflect the increasing importance attached to marine resources within biotechnological practices that can help address world challenges thus promoting sustainability all over again.

• Marine Genomics and Synthetic Biology: Marine genomics and synthetic biology are causing an upheaval in the blue biotechnology market through enabling discovery and manipulation of marine genetic materials. Advances in sequencing technologies have unveiled new marine organisms and their unique characteristics, leading to novel biotechnological applications. In fact, synthetic biology is boosting efficiencies in creating customized marine-based products hence enhancing the overall effectiveness of the field of marine biotechnology. This wave is growing the areas where research on marine applicability can be done further.
• Sustainable Aquaculture Practices: In a world that has seen an increase in demand for seafood and other marine resources, sustainable aquaculture practices have become central to developments within the blue-biotechnology market. These include innovative aquaculture technologies aimed at reducing environmental impacts, improving resource efficiency as well as fish health. Sustainable feed development strategies, disease management approaches and breeding techniques are some of these practices. Thereby, this focus on sustainability is fostering growth in this sector while promoting responsible management of our marine resources.
• Marine-Derived Pharmaceuticals: Scientists are now focusing on the therapeutic potential of marine organisms resulting in the growing need for effective treatments such as marine derived pharmaceuticals. With advances in drug discovery from oceans comes hope for developing alternative medicines against various diseases including cancer, infections, neurological disorders among others. For example; algal sponges or microorganisms found within them not only produce bioactive compounds but also possess therapeutic properties which have made them very useful sources for developing drugs. Indeed it's a progression towards innovation in drug development as well as extending its horizon within pharma sectors.
• Bioremediation and Environmental Protection: One emerging trend in blue-biotech is using marine organisms to solve ecological issues -bioremediation and environmental protection-. Marine bacteria, algae among other species are currently being assessed for their potential use in break-down of pollutants like oil spills remediation and restoration of degraded ecosystems. These applications are contributing to environmental sustainability and highlighting the potential of marine biotechnology to support ecological health and resilience. This has been achieved through using marine biotechnology in addressing a range of environment problems facing people.

Marine genomics, sustainable aquaculture practices, marine derived pharmaceuticals, bioremediation, and marine-based nutraceuticals are some of the emerging trends within blue-biotech sector that are transforming this industry. It's this ongoing change which fuels invention thus widening its boundaries while overlooking such global issues as environmental conservationism and healthcare matters among others. The promising future prospect for the blue technological development hints at tremendous scientific discoveries and technological advancements offering new opportunities for growth in different areas as blue biotech continues evolving rapidly in future years ahead.

Recent Developments in the Blue Biotechnology Market

The recent developments in the blue biotechnology market highlight the significant strides made in the use of marine resources for different purposes. The sector is being transformed by advancements in marine genomics, bioprocessing technologies, and sustainable practices. These advances are improving the prospects of marine organisms as far as pharmaceuticals, environmental management, and agriculture are concerned.

• Marine Genomics Progress: The advancement of marine genomics has provided an opportunity to discover novel marine organisms with unique genetic properties. This breakthrough enables development of various biotechnological applications including: marine derived pharmaceuticals or bioactive compounds among others. The availability of sequencing and analyzing marine genomes provides avenues for research and product development; thereby driving growth within the blue biotech field.
• Bioprocessing Technologies Revolution: Progresses in bioprocessing technologies have raised efficiency levels regarding extraction and utilization of marine based resources. Consequently, there are developments aimed at enhancing yield and quality improvement of such products like enzymes, bioactive molecules derived from oceans. These innovations facilitate sector-wide production streamlining that ensures cost minimization making more enterprises based on oceanic life forms commercially viable.
• Sustainable Management of Ocean Resources: In reality, sustainable practices in managing ocean resources have become a vital focus area within Blue Biotech field. Monitoring harvesting processes with a view to conserving ocean species is key to protecting biodiversity & ecosystem health. Such initiatives help reduce environmental impact as well as promote sustainability necessary for long term growth within a blue biological market where issues such as over-exploitation or ecological balance should be addressed.
• Marine-Derived Pharmaceuticals: The advent of Marine Derived Pharmaceuticals has been a major boost to blue biotechnology industry. Presently, research into these creatures has discovered therapeutic compounds, which can be used to cure ailments including cancer, infections and neurological disorders. This shift has led to diversification of treatments in the market while emphasizing on the importance of marine biodiversity with reference to drug discovery and development.

Blue biotechnology market has been characterized by recent developments in marine genomics, innovative bioprocessing technologies and sustainable practices that are bringing out transformative changes. The search for marine-derived pharmaceuticals and nutraceuticals is widening up treatment options and health gains. Therefore, these developments demonstrate the increasing importance of marine resources in biotech industry which can be applied to address major worldwide challenges.

Strategic Growth Opportunities for Blue Biotechnology Market

Strategic growth opportunities exist within different applications of blue biotech that has been brought about by progress in marine research and technology. These openings define future trends in the business implying a fresh start point for invention purposes.

• Pharmaceutical Applications: The pharmaceutical industry is growing through advancements in medicaments obtained from sea species. On an experimental basis, marine organisms are appealing since they have potentiality for generating new drugs against various diseases. Therefore, this avenue promotes research efforts and investments into Blue Biotechnology thereby leading to development of new medicines or widening treatment options for several health conditions
• Environmental Management and Bioremediation: Significant opportunities in environmental management and bioremediation are offered by marine biotechnology. There is rising use of marine organisms to address pollution and restore damage done to ecosystems through processes such as biotransformation and bioremediation. These applications promote environmental sustainability, while also showcasing the potential of marine resources for dealing with ecological challenges and enhancing ecosystem health.
• Aquaculture and Sustainable Seafood Production: An important growth opportunity exists in the blue biotechnology market with respect to sustainable aquaculture practices. Innovations in aquaculture technologies and practices are directed at improving efficiency, minimizing environmental degradation, and boosting fish health. This opportunity underpins the growing market for sustainable seafood production while conforming to global efforts aimed at encouraging responsible management of marine resources.
• Nutraceuticals and Functional Foods: The development of nutraceuticals and functional foods on the basis of marine sources is a burgeoning business prospect. Such examples include dietary supplements or functional ingredients made from living things found in the sea. In this way, it is driving what consumers want, expanding markets for food from the ocean that has been extracted emphasizing its nutritional value as well as its function in maintenance of good health.

Strategic growth opportunities are being seen within several areas such as pharmaceuticals, environmental management, sustainable aquaculture, nutraceuticals and industrial processes across various applications. These are creating new solutions for global problems by using sea products. The sector's focus on sustainability practices and advanced technologies is leading to new ways of growing it. Therefore, health care industry would see significant contributions towards health maintenance; environment conservation while improving industrial efficiency through capitalizing on these prospects which will shape future trends of blue biotech expanding its influence into other fields.

Blue Biotechnology Market Driver and Challenges

Many drivers and challenges influence the blue biotechnology market including technological, economic, and regulatory factors. These factors must be understood in order to effectively navigate the market and identify opportunities for growth. Additionally, the development and adoption of marine biotechnology solutions are shaped by key drivers and challenges.

The factors responsible for driving the blue biotechnology market include:

1. Technological Advancements: The Blue Biotechnology market is being driven forward by technological advancements in marine genomics, bioprocessing as well as analytical tools. The research involved has seen great strides taken towards increased efficiency and effectiveness when it comes to how we use our seas best resource while at same time finding out more about them .These innovations are broadening horizons with regard to study possibilities, leading to novel products/ materials that can be used commercially.

2. Growing Demand for Sustainable Solutions: There is an increasing demand for sustainable and eco-friendly solutions which has led to adoption of Blue Biotechnology. This surge in demand has resulted into environmentally friendly products or services from both consumers' sides hence enabling various marine businesses which are mainly concerned with managing environment produce good effects on ecological systems due environmental management practices that have less impact on surroundings. This trend encourages sustainable biotech applications as it affects market dynamics.

3. Investment in Research and Development: Investment in Research and Development is one of the driving forces behind innovation in the blue biotechnology market. Marine biotech research as well as new technologies/products development benefits from funds originating from either governments or private sectors among other institutions around world. Such kind of investment also paves way for scientific knowledge advancement fostering innovations leading improved business environments.

Challenges in the blue biotechnology market are:

1. Regulatory and Environmental Compliance: Blue biotechnology faces many difficulties regarding regulatory and environmental compliance. There are stringent laws governing fishing grounds protection, product safety etc., all of which could hinder their development into attractive commercial items. For this reason, firms operating within this sector must adhere strictly to these regulations so that they don't end up facing legal claims but instead move forward with their business.

2. Market Competition and Commercialization: Blue biotechnology market's competitive environment and commercialization challenges can influence growth and profits. In this case, firms face both rivals who have long established their presence in the industry as well as new entrants; thus, successful commercialization of marine-based products requires an innovative approach and effective marketing strategies. These are the challenges that must be met to ensure that the market is a profitable venture.

The blue biotechnology sector has experienced tremendous growth due to advancements in marine genomics, bioprocessing technology, sustainable practices, pharmaceuticals derived from marine organisms, and marine nutraceuticals. The industry's future will be shaped by strategic expansion opportunities for applications including industrial products, pharmaceuticals, and environmental management aquaculture among others. However technological changes, regulations compliance as well as competition within the market presents both opportunities and threats.

List of Blue Biotechnology Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies blue biotechnology companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the blue biotechnology companies profiled in this report include-

• Aker BioMarine
• Marinova
• New England BioLabs
• PML Applications
• Sea Run Holdings
• PICES
• Donald Danforth Plant Science Center
• Shell Marine Products
• Geomarine Biotechnologies
• GlycoMar

Blue Biotechnology by Segment

The study includes a forecast for the global blue biotechnology by product, application, end use, and region.

Blue Biotechnology Market by Product [Analysis by Value from 2018 to 2030]:

• Enzymes
• Pharma Products
• Bulk Chemicals
• Biopolymers
• Others

Blue Biotechnology Market by Application [Analysis by Value from 2018 to 2030]:

• Bioengineering
• Genomics
• Vaccine Development
• Drug Discovery
• Others

Blue Biotechnology Market by End Use [Analysis by Value from 2018 to 2030]:

• Hospitals
• Pharmaceutical Companies
• Biotechnology Companies
• Research Institutes
• Laboratories
• Others

Blue Biotechnology Market by Region [Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Blue Biotechnology Market

In recent times, the blue biotechnology market shows some remarkable achievements in marine resources advancement and their utilization in several industries. The market is growing due to increased research of sea organisms and their specific properties; among these areas are pharmaceuticals, environmental protection measures, and agriculture. New biotechnological innovations capitalize on marine biodiversity towards realization of novel products and solutions that address world challenges such as diseases, global warming, and food insecurity.

• United States: The United States has seen a rapid growth within the blue biotechnology market with more investments being made into marine genomics as well as biotechnology research. Among notable advances include development of new drugs from marine organisms and novel industrial enzymes derived from the same source. Marine conservation along with sustainability efforts are increasingly being pursued by the U.S through several initiatives aimed at turning this resources to benefit environmentally or health wise. These recent developments have positioned US among leaders in Marine Biotechnology and its applications.
• China: China's blue biotech industry has expanded substantially due to large-scale investments made on studying marine resources and conducting bio-technological researches. Some important milestones include breakthroughs on finding new drugs from sea life mainly for cancer treatment purposes or antiviral substances. China is also focusing on sustainable aquaculture practices besides using marine biotech for managing water resources. The above describe China's commitment to harnessing her oceanic endowments for scientific gains as well as economic benefits.
• Germany: There have been recent advancements within Germany's blue bio-technology which concern studies on varieties of microorganisms found in oceans plus other biologicals based on them. The latest developments encompass utilizing seaweed and bacteria for medicines producing cosmetics together with engineering application. Marine biodiversity research is another area of investment in Germany aimed at supporting sustainability and protecting environment. These efforts are elevating the status of Germany in the global blue biotechnology market and are translating into innovative uses of marine materials.
• India: The country's blue biotechnology market is on an upward trajectory and focuses more on marine bioresources use. Important breakthroughs include researches on marine algae for jet fuel and food supplements as well as new types of drugs from sea. India has also researched sustainable fish farming and resource management within its emerging blue biotech industry context. There are several such developments that highlight India's potential to exploit her vast marine resources for various biotechnological applications hence sustainable development.
• Japan: Through significant investments in marine biotechnology research, Japan leads in blue bio-technology applications worldwide. Recent breakthroughs involve using life forms from water bodies mostly applied to finding neurodegenerative diseases cure. As far as this nation is concerned, it is leading in matters related to restoration of oceans through biological mechanisms and production of environmentally friendly seafood. Japan, pushing forward its own blue biodiversity, aims to respond better health-wise and ecologically by advancing blue biotechnology.

Features of the Global Blue Biotechnology Market

Market Size Estimates: Blue biotechnology market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Blue biotechnology market size by product, application, end use, and region in terms of value ($B).

Regional Analysis: Blue biotechnology market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different products, applications, end uses, and regions for the blue biotechnology market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the blue biotechnology market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

FAQ

Q1. What is the growth forecast for blue biotechnology market?

Answer: The global blue biotechnology market is expected to grow with a CAGR of 13.9% from 2024 to 2030.

Q2. What are the major drivers influencing the growth of the blue biotechnology market?

Answer: The major drivers for this market are increasing demand in the pharmaceutical and cosmetics sectors and growing R&D expenditures and initiatives.

Q3. What are the major segments for blue biotechnology market?

Answer: The future of the blue biotechnology market looks promising with opportunities in the hospitals, pharmaceutical companies, biotechnology companies, research institutes, and laboratories markets.

Q4. Who are the key blue biotechnology market companies?

Answer: Some of the key blue biotechnology companies are as follows:

• Aker BioMarine
• Marinova
• New England BioLabs
• PML Applications
• Sea Run Holdings
• PICES
• Donald Danforth Plant Science Center
• Shell Marine Products
• Geomarine Biotechnologies
• GlycoMar

Q5. Which blue biotechnology market segment will be the largest in future?

Answer: Lucintel forecasts that enzymes is expected to witness the highest growth over the forecast period.

Q6. In blue biotechnology market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to the presence of improved and advanced healthcare and research facilities in the region.

Q7. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the blue biotechnology market by product (enzymes, pharma products, bulk chemicals, biopolymers, and others), application (bioengineering, genomics, vaccine development, drug discovery, and others), end use (hospitals, pharmaceutical companies, biotechnology companies, research institutes, laboratories, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
• Market Report

Table of Contents

1. Executive Summary

2. Global Blue Biotechnology Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Blue Biotechnology Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Blue Biotechnology Market by Product
  • 3.3.1: Enzymes
  • 3.3.2: Pharma Products
  • 3.3.3: Bulk Chemicals
  • 3.3.4: Biopolymers
  • 3.3.5: Others
• 3.4: Global Blue Biotechnology Market by Application
  • 3.4.1: Bioengineering
  • 3.4.2: Genomics
  • 3.4.3: Vaccine Development
  • 3.4.4: Drug Discovery
  • 3.4.5: Others
• 3.5: Global Blue Biotechnology Market by End Use
  • 3.5.1: Hospitals
  • 3.5.2: Pharmaceutical Companies
  • 3.5.3: Biotechnology Companies
  • 3.5.4: Research Institutes
  • 3.5.5: Laboratories
  • 3.5.6: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Blue Biotechnology Market by Region
• 4.2: North American Blue Biotechnology Market
  • 4.2.1: North American Blue Biotechnology Market by Product: Enzymes, Pharma Products, Bulk Chemicals, Biopolymers, and Others
  • 4.2.2: North American Blue Biotechnology Market by End Use: Hospitals, Pharmaceutical Companies, Biotechnology Companies, Research Institutes, Laboratories, and Others
• 4.3: European Blue Biotechnology Market
  • 4.3.1: European Blue Biotechnology Market by Product: Enzymes, Pharma Products, Bulk Chemicals, Biopolymers, and Others
  • 4.3.2: European Blue Biotechnology Market by End Use: Hospitals, Pharmaceutical Companies, Biotechnology Companies, Research Institutes, Laboratories, and Others
• 4.4: APAC Blue Biotechnology Market
  • 4.4.1: APAC Blue Biotechnology Market by Product: Enzymes, Pharma Products, Bulk Chemicals, Biopolymers, and Others
  • 4.4.2: APAC Blue Biotechnology Market by End Use: Hospitals, Pharmaceutical Companies, Biotechnology Companies, Research Institutes, Laboratories, and Others
• 4.5: ROW Blue Biotechnology Market
  • 4.5.1: ROW Blue Biotechnology Market by Product: Enzymes, Pharma Products, Bulk Chemicals, Biopolymers, and Others
  • 4.5.2: ROW Blue Biotechnology Market by End Use: Hospitals, Pharmaceutical Companies, Biotechnology Companies, Research Institutes, Laboratories, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Blue Biotechnology Market by Product
  • 6.1.2: Growth Opportunities for the Global Blue Biotechnology Market by Application
  • 6.1.3: Growth Opportunities for the Global Blue Biotechnology Market by End Use
  • 6.1.4: Growth Opportunities for the Global Blue Biotechnology Market by Region
• 6.2: Emerging Trends in the Global Blue Biotechnology Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Blue Biotechnology Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Blue Biotechnology Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Aker BioMarine
• 7.2: Marinova
• 7.3: New England BioLabs
• 7.4: PML Applications
• 7.5: Sea Run Holdings
• 7.6: PICES
• 7.7: Donald Danforth Plant Science Center
• 7.8: Shell Marine Products
• 7.9: Geomarine Biotechnologies
• 7.10: GlycoMar